source
- STAT+: Apple and OpenEvidence launch experimental health chat appApple and OpenEvidence are launching a study based around an experimental AI-powered health chat app, hinting at possible new directions for both companies.STAT · 1h ago↗ source
- FDA rejects Summit and Akeso's ivonescimab for narrow lung cancerThe U.S. Food and Drug Administration has turned down ivonescimab, a new cancer therapy being developed by Summit Therapeutics and Akeso, for use in a specific type of lung cancer. Analysts had la…